BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 26675563)

  • 1. The impact of angiotensin II type 1 receptor antibodies on post-heart transplantation outcome in Heart Mate II bridged recipients.
    Urban M; Slavcev A; Gazdic T; Ivak P; Besik J; Netuka I
    Interact Cardiovasc Thorac Surg; 2016 Mar; 22(3):292-7. PubMed ID: 26675563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin II Type 1 Receptor Antibody-mediated Rejection Following Orthotopic Heart Transplant: A Single-center Experience.
    Moreno JD; Verma AK; Kopecky BJ; Dehner C; Kostelecky N; Vader JM; Lin CY; Schilling JD
    Transplantation; 2022 Feb; 106(2):373-380. PubMed ID: 33988339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical conundrums in pediatric kidney transplantation: What we know about the role of angiotensin II type I receptor antibodies in pediatric kidney transplantation and the path forward.
    Pearl MH
    Pediatr Transplant; 2024 May; 28(3):e14762. PubMed ID: 38650537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin II type 1 receptor antibodies and native kidney function in pediatric liver and intestinal transplant recipients.
    Stern R; Chen L; Chan AP; Wozniak LJ; Pearl M
    Pediatr Nephrol; 2023 Dec; 38(12):4175-4185. PubMed ID: 37432534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-HLA Antibodies to G Protein-coupled Receptors in Pediatric Kidney Transplant Recipients: Short- and Long-term Clinical Outcomes.
    Pearl MH; Chen L; Zuckerman JE; Weng PL; Chambers ET; Zhang Q; Reed EF
    Transplantation; 2024 Jan; 108(1):276-283. PubMed ID: 37527494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies against Angiotensin II Type 1 and Endothelin A Receptors: Relevance and pathogenicity.
    Philogene MC; Johnson T; Vaught AJ; Zakaria S; Fedarko N
    Hum Immunol; 2019 Aug; 80(8):561-567. PubMed ID: 31010696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post-transplant survival with pre-transplant durable continuous-flow mechanical circulatory support in a Swiss cohort of heart transplant recipients.
    Hullin R; Abdurashidova T; Pitta-Gros B; Schukraft S; Rancati V; Lu H; Zurbuchen A; Marcucci C; Ltaief Z; Lefol K; Huber C; Pascual M; Tozzi P; Meyer P; Kirsch M
    Swiss Med Wkly; 2023 Dec; 153():3500. PubMed ID: 38579299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival After Simultaneous Heart-kidney Transplant in Recipients With a Durable LVAD and Chronic Kidney Disease: Effect of the 2018 Heart Allocation Policy Change.
    Fraser M; Agdamag AC; Riad S; Nzemenoh BN; Jackson S; Money J; Knoper R; Martin CM; Alexy T
    Transplantation; 2024 Feb; 108(2):524-529. PubMed ID: 37677944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three year post heart transplant outcomes of desensitized durable mechanical circulatory support patients.
    Youn JC; Kim D; Jung MH; Kim JJ; Kim IC; Lee HS; Choi JO; Jeon ES; Nishihara K; Seguchi O; Kransdorf EP; Chang DH; Kittleson MM; Patel JK; Cole RM; Moriguchi JD; Ramzy D; Esmailian F; Kobashigawa JA
    J Heart Lung Transplant; 2023 Oct; 42(10):1408-1414. PubMed ID: 37150473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival Outcomes After Heart Transplantation: Does Recipient Sex Matter?
    Moayedi Y; Fan CPS; Cherikh WS; Stehlik J; Teuteberg JJ; Ross HJ; Khush KK
    Circ Heart Fail; 2019 Oct; 12(10):e006218. PubMed ID: 31597452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bridge-to-transplant temporary mechanical circulatory support and risk of allosensitization.
    Sideris K; Lázár-Molnár E; Kyriakopoulos CP; Taleb I; Hurst D; Ugolini S; Selzman CH; Brinker L; Drakos SG; Tonna JE; Geer L; Goodwin ML; Wever-Pinzon O; Hanff TC; Fang JC; Carter S; Stehlik J
    Clin Transplant; 2024 May; 38(5):e15330. PubMed ID: 38716787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin II Type 1 Receptor Autoantibodies in Postural Tachycardia Syndrome.
    Yu X; Li H; Murphy TA; Nuss Z; Liles J; Liles C; Aston CE; Raj SR; Fedorowski A; Kem DC
    J Am Heart Assoc; 2018 Apr; 7(8):. PubMed ID: 29618472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk Factors for 1-Year Mortality After Heart Transplant in Obese Patients Bridged With an LVAD.
    Bhandari K; Sama V; Shorbaji K; Witer L; Houston BA; Tedford RJ; Welch B; Kilic A
    Ann Thorac Surg; 2024 Feb; 117(2):404-411. PubMed ID: 37479131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamics of HLA and angiotensin II type 1 receptor antibodies during pregnancy.
    Burballa C; Llinàs-Mallol L; Vázquez S; Pérez-Sáez MJ; Arias-Cabrales C; Buxeda A; Hernandez JL; Riera M; Sanz S; Alari-Pahissa E; Federico-Vega J; Eguía J; Pascual J; Redondo-Pachón D; Crespo M
    Hum Immunol; 2024 Mar; 85(2):110749. PubMed ID: 38238229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heart transplantation and anti-HLA antibodY: myocardial dysfunction and prognosis - HeartLAy study.
    Sciaccaluga C; Natali BM; Righini FM; Sorini Dini C; Landra F; Mandoli GE; Sisti N; Menci D; D'Errico A; D'Ascenzi F; Focardi M; Bernazzali S; Maccherini M; Valente S; Cameli M
    ESC Heart Fail; 2023 Oct; 10(5):2853-2864. PubMed ID: 37415291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome-based Risk Assessment of Non-HLA Antibodies in Heart Transplantation: A Systematic Review.
    Panicker AJ; Prokop LJ; Hacke K; Jaramillo A; Griffiths LG
    J Heart Lung Transplant; 2024 May; ():. PubMed ID: 38796046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How can we better inform our patients about post-heart transplantation survival? A conditional survival analysis.
    Clerkin KJ; Griffin JM; Fried JA; Raikhelkar J; Jain R; Topkara VK; Habal MV; Latif F; Restaino S; Colombo PC; Takeda K; Naka Y; Farr MA; Sayer G; Uriel N
    Clin Transplant; 2021 Nov; 35(11):e14449. PubMed ID: 34363421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Machine Learning Algorithm Improves the Diagnostic Accuracy of the Histologic Component of Antibody Mediated Rejection (AMR-H) in Cardiac Transplant Endomyocardial Biopsies.
    Glass M; Ji Z; Davis R; Pavlisko E; DiBernardo L; Carney J; Fishbein G; Luthringer D; Miller D; Mitchell R; Larsen B; Butt Y; Bois M; Maleszewski J; Halushka M; Seidman M; Lin CY; Buja M; Stone J; Dov D; Carin L; Glass C
    Cardiovasc Pathol; 2024 Apr; ():107646. PubMed ID: 38677634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Importance of social vulnerability on long-term outcomes after heart transplantation.
    Suarez-Pierre A; Iguidbashian J; Kirsch MJ; Cotton JL; Quinn C; Fullerton DA; Reece TB; Hoffman JRH; Cleveland JC; Rove JY
    Am J Transplant; 2023 Oct; 23(10):1580-1589. PubMed ID: 37414250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bariatric surgery modulates plasma levels of antibodies against angiotensin II type 1 and endothelin 1 type A receptor in severe obesity.
    Di Vincenzo A; Granzotto M; Trevellin E; Purificati C; Vecchiato M; Foletto M; Pesavento M; Vettor R; Rossato M
    J Endocrinol Invest; 2024 Jun; ():. PubMed ID: 38900373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.